Circulating MiRNAs in the First Trimester and Pregnancy Complications: a Systematic Review

Overview

Journal Epigenetics

Specialty Genetics

Date 2022 Dec 12

PMID 36503407

Authors

Anita Subramanian

Doria Weiss

Kate Nyhan

Andrew DeWan

Anne Marie Z Jukic

Affiliations

Soon will be listed here.

Abstract

Most pregnancy complications originate with early placentation. MicroRNAs (miRNAs) may play an important role in placentation and function as biomarkers of future pregnancy complications. We summarized from the literature all first trimester circulating miRNAs associated with pregnancy complications of placental origin and further identified the miRNAs which have the most evidence as potential early biomarkers for pregnancy complications. We conducted a systematic review following PRISMA reporting guidelines (PROSPERO CRD42020183421). We identified all first trimester serum or plasma miRNAs associated with a pregnancy complication of placental origin (preeclampsia, intrauterine growth restriction (IUGR), gestational hypertension, preterm delivery) and the number of times those miRNAs were identified, as a measure of replication. Twenty-one studies examined 118 unique miRNAs, and 87 were associated with at least one pregnancy complication; preeclampsia was the most common. Seven miRNAs were significantly associated with a pregnancy complication in at least two studies: miR-125b, miR-518b, miR-628-3p, miR-365a-3p, miR-520h, miR-374a-5p, miR-191-5p. Few miRNAs were associated with more than one pregnancy complication: miR-518b and miR-520h with preeclampsia and gestational hypertension, miR-374a-5p and miR-191-5p with preterm birth and preeclampsia. Our systematic review suggests seven miRNAs as potential biomarkers of pregnancy complications. These complications are thought to originate with early placental defects and these miRNAs may also be biomarkers of placental pathology. First-trimester biomarkers of pregnancy complications can facilitate early detection and interventions.

Citing Articles

Urinary miRNA Expression in Pre-Eclampsia During Early and Mid-Pregnancy.

Illarionov R, Maltseva A, Pachuliia O, Postnikova T, Vashukova E, Popova A Noncoding RNA. 2024; 10(6).

PMID: 39728606 PMC: 11677131. DOI: 10.3390/ncrna10060061.

Maternal Plasma miRNAs as Early Biomarkers of Moderate-to-Late-Preterm Birth.

Ramzan F, Rong J, Roberts C, OSullivan J, Perry J, Taylor R Int J Mol Sci. 2024; 25(17).

PMID: 39273483 PMC: 11394737. DOI: 10.3390/ijms25179536.

Potential epigenetic markers of clinical diagnostics/therapeutic targets in preeclampsia.

de Oliveira Cruz J, Luizon M Epigenomics. 2024; 16(15-16):1057-1060.

PMID: 39115080 PMC: 11418293. DOI: 10.1080/17501911.2024.2383558.

Association between miRNAs in serum at 10-14 gestational weeks and spontaneous preterm delivery.

Wikstrom T, Kim S, Leverin A, Wennerholm U, Jacobsson B, Valentin L Acta Obstet Gynecol Scand. 2024; 103(10):2013-2023.

PMID: 39034527 PMC: 11426222. DOI: 10.1111/aogs.14926.

First Trimester Placental Biomarkers for Pregnancy Outcomes.

Cristodoro M, Messa M, Tossetta G, Marzioni D, DellAvanzo M, Inversetti A Int J Mol Sci. 2024; 25(11).

PMID: 38892323 PMC: 11172712. DOI: 10.3390/ijms25116136.

References

Romero R, Dey S, Fisher S . Preterm labor: one syndrome, many causes. Science. 2014; 345(6198):760-5. PMC: 4191866. DOI: 10.1126/science.1251816. View

Jiang L, Long A, Tan L, Hong M, Wu J, Cai L . Elevated microRNA-520g in pre-eclampsia inhibits migration and invasion of trophoblasts. Placenta. 2017; 51:70-75. DOI: 10.1016/j.placenta.2017.02.001. View

Butler A, Cunningham T, Ramachandran V, Diboun I, Halama A, Sathyapalan T . Association of microRNAs With Embryo Development and Fertilization in Women Undergoing Subfertility Treatments: A Pilot Study. Front Reprod Health. 2022; 3:719326. PMC: 9580729. DOI: 10.3389/frph.2021.719326. View

Kim S, MacIntyre D, Binkhamis R, Cook J, Sykes L, Bennett P . Maternal plasma miRNAs as potential biomarkers for detecting risk of small-for-gestational-age births. EBioMedicine. 2020; 62:103145. PMC: 7708817. DOI: 10.1016/j.ebiom.2020.103145. View

Wang Y, Zhang S, Bao H, Mu S, Zhang B, Ma H . MicroRNA-365 promotes lung carcinogenesis by downregulating the USP33/SLIT2/ROBO1 signalling pathway. Cancer Cell Int. 2018; 18:64. PMC: 5930950. DOI: 10.1186/s12935-018-0563-6. View

Hromadnikova I, Kotlabova K, Hympanova L, Doucha J, Krofta L . First trimester screening of circulating C19MC microRNAs can predict subsequent onset of gestational hypertension. PLoS One. 2014; 9(12):e113735. PMC: 4266496. DOI: 10.1371/journal.pone.0113735. View

Li Q, Han Y, Xu P, Yin L, Si Y, Zhang C . Elevated microRNA-125b inhibits cytotrophoblast invasion and impairs endothelial cell function in preeclampsia. Cell Death Discov. 2020; 6:35. PMC: 7220944. DOI: 10.1038/s41420-020-0269-0. View

Page M, Moher D, Bossuyt P, Boutron I, Hoffmann T, Mulrow C . PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ. 2021; 372:n160. PMC: 8005925. DOI: 10.1136/bmj.n160. View

Yin L, Xiao X, Georgikou C, Yin Y, Liu L, Karakhanova S . MicroRNA-365a-3p inhibits c-Rel-mediated NF-κB signaling and the progression of pancreatic cancer. Cancer Lett. 2019; 452:203-212. DOI: 10.1016/j.canlet.2019.03.025. View

10.

Chaddha V, Viero S, Huppertz B, Kingdom J . Developmental biology of the placenta and the origins of placental insufficiency. Semin Fetal Neonatal Med. 2005; 9(5):357-69. DOI: 10.1016/j.siny.2004.03.006. View

11.

Barchitta M, Maugeri A, Quattrocchi A, Agrifoglio O, Agodi A . The Role of miRNAs as Biomarkers for Pregnancy Outcomes: A Comprehensive Review. Int J Genomics. 2017; 2017:8067972. PMC: 5572592. DOI: 10.1155/2017/8067972. View

12.

Burton G, Jauniaux E, Charnock-Jones D . The influence of the intrauterine environment on human placental development. Int J Dev Biol. 2009; 54(2-3):303-12. DOI: 10.1387/ijdb.082764gb. View

13.

Fu G, Brkic J, Hayder H, Peng C . MicroRNAs in Human Placental Development and Pregnancy Complications. Int J Mol Sci. 2013; 14(3):5519-44. PMC: 3634453. DOI: 10.3390/ijms14035519. View

14.

Chen D, Wang W . Human placental microRNAs and preeclampsia. Biol Reprod. 2013; 88(5):130. PMC: 4013914. DOI: 10.1095/biolreprod.113.107805. View

15.

Timofeeva A, Gusar V, Kan N, Prozorovskaya K, Karapetyan A, Bayev O . Identification of potential early biomarkers of preeclampsia. Placenta. 2017; 61:61-71. DOI: 10.1016/j.placenta.2017.11.011. View

16.

Hromadnikova I, Kotlabova K, Doucha J, Dlouha K, Krofta L . Absolute and relative quantification of placenta-specific micrornas in maternal circulation with placental insufficiency-related complications. J Mol Diagn. 2012; 14(2):160-7. DOI: 10.1016/j.jmoldx.2011.11.003. View

17.

Luque A, Farwati A, Crovetto F, Crispi F, Figueras F, Gratacos E . Usefulness of circulating microRNAs for the prediction of early preeclampsia at first-trimester of pregnancy. Sci Rep. 2014; 4:4882. PMC: 4013938. DOI: 10.1038/srep04882. View

18.

Zhong Y, Zhu F, Ding Y . Differential microRNA expression profile in the plasma of preeclampsia and normal pregnancies. Exp Ther Med. 2019; 18(1):826-832. PMC: 6591498. DOI: 10.3892/etm.2019.7637. View

19.

Hromadnikova I, Kotlabova K, Ivankova K, Krofta L . First trimester screening of circulating C19MC microRNAs and the evaluation of their potential to predict the onset of preeclampsia and IUGR. PLoS One. 2017; 12(2):e0171756. PMC: 5300267. DOI: 10.1371/journal.pone.0171756. View

20.

Sheikh A, Small H, Currie G, Delles C . Systematic Review of Micro-RNA Expression in Pre-Eclampsia Identifies a Number of Common Pathways Associated with the Disease. PLoS One. 2016; 11(8):e0160808. PMC: 4986940. DOI: 10.1371/journal.pone.0160808. View